Spearhead Capital Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$209K Sell
752
-902
-55% -$229K 0.23% 94
2022
Q2
$316K Sell
1,654
-23
-1% -$4.06K 0.05% 117
2022
Q1
$348K Buy
+1,677
New +$276K 0.04% 115

Other funds holding SWAV

Spearhead Capital Advisors's SWAV Position: Q3 2022 in Review

Spearhead Capital Advisors reduced its Shockwave Medical, Inc. Common Stock (SWAV) stake by 55% in Q3 2022, selling an estimated $229K and leaving 752 shares worth $209K. The position accounts for 0.23% of the portfolio, ranked #94.

Spearhead Capital Advisors first reported a position in SWAV in Q1 2022 and has held it in 3 quarters since. The position peaked at $348K in Q1 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2022.

  • Spearhead Capital Advisors held 752 shares of Shockwave Medical, Inc. Common Stock worth $209K as of Q3 2022.
  • Spearhead Capital Advisors sold 902 Shockwave Medical, Inc. Common Stock shares in Q3 2022, an estimated $229K.
  • Shockwave Medical, Inc. Common Stock made up 0.23% of Spearhead Capital Advisors's portfolio in Q3 2022, its #94 holding.
  • Spearhead Capital Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and has held it in 3 quarters since.
  • Spearhead Capital Advisors's Shockwave Medical, Inc. Common Stock position peaked at $348K in Q1 2022.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.